Pfizer unleashes its stake in GSK's ViiV Healthcare for $1.9B
|
In 2024, GSK reported sales of its HIV treatments
at 7.1 billion pounds sterling ($9.1 billion), trailing its primary rival in
the market, Gilead ... |
Top 10 counties in new HIV infections
In 2024, Kenya witnessed a concerning rise in new HIV infections, with the total number increasing by 19% from 16752 cases in 2023 to 19991. View article...